AKT1 and diabetic kidney disease: Dusabimana et al. [19] found that AKT was activated in the DKD mouse model and subsequently phosphorylated GSK-3β (Ser-9) which was the inhibitory site of GSK-3β, thereby inhibiting GSK-3β activity.